 |
Journal articles
Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.
Jean-Louis Montastruc
1, 2, *
Anne Charlotte Danton
1, 2
Genevieve Durrieu
1, 2
Isabelle Lacroix
1, 2
Pascale Olivier
1, 2
Agnés Sommet
1, 2
Jean-Michel Senard
1, 2
Jean-Louis Montastruc 1, 2
Correspondent author
Anne Charlotte Danton 1, 2
Author
Genevieve Durrieu 1, 2
Author
Isabelle Lacroix 1, 2
Author
1
Service de Pharmacologie Médicale (Faculte de Medecine PURPAN 37, allées Jules Guesde BP 7072 31073 TOULOUSE CEDEX 7 - France)
- UT3 - Université Toulouse III - Paul Sabatier : EA3696 (118 route de Narbonne - 31062 Toulouse - France)
- Université Fédérale Toulouse Midi-Pyrénées (41 Allée Jules Guesde, 31000 Toulouse - France)
2
Faculté de Médecine (37 allées Jules-Guesde, Toulouse - France)
- CHU Toulouse [Toulouse] (Hôtel-Dieu Saint Jacques 2, rue Viguerie TSA 80035 31059 Toulouse cedex 9 - France)
Document type :
Journal articles
Complete list of metadata
https://www.hal.inserm.fr/inserm-00504994
Contributor : Marie Francoise Simon <>
Submitted on : Thursday, July 22, 2010 - 11:07:38 AM
Last modification on : Wednesday, June 16, 2021 - 9:46:10 AM
Contributor : Marie Francoise Simon <>
Submitted on : Thursday, July 22, 2010 - 11:07:38 AM
Last modification on : Wednesday, June 16, 2021 - 9:46:10 AM
Links full text
Identifiers
- HAL Id : inserm-00504994, version 1
- DOI : 10.1002/mds.22878
- PUBMED : 20213824
Collections
Citation
Jean-Louis Montastruc, Anne Charlotte Danton, Genevieve Durrieu, Isabelle Lacroix, Pascale Olivier, et al.. Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.. Movement Disorders, Wiley, 2010, 25 (5), pp.660-1. ⟨10.1002/mds.22878⟩. ⟨inserm-00504994⟩
Metrics
Record views